HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunotherapy of murine transitional cell carcinoma of the bladder using alpha and gamma interferon in combination with other forms of immunotherapy.

Abstract
BCG immunotherapy is very effective in the treatment of superficial transitional cell carcinoma of the bladder, but its significant toxicity may limit its use in some patients. In an effort to find less toxic and potentially more effective treatments we investigated the possible immunotherapeutic potential of combinations of Alpha Interferon (1000 IU) and Gamma Interferon (500 IU) with bacillus Calmette Guerin (BCG) (10(7) cfu), Interleukin-2 (4000 IU), and Keyhole Limpet Hemocyanin (50 micrograms.) in the MBT2 murine bladder cancer model. Significant reductions (p less than 0.05) in tumor incidence relative to the saline control, 83%, Day 35) was observed in groups receiving alpha interferon (42%), Keyhole limpet hemocyanin (42%), interleukin-2 (25%), alpha interferon + Keyhole limpet hemocyanin (17%), alpha interferon + interleukin-2 (33%), gamma interferon + BCG (42%), and gamma interferon + interleukin-2 (17%). All treatment groups with the exception of the group receiving gamma interferon had significantly reduced tumor volume (p less than 0.05) relative to the saline control. Combination treatment groups were significantly more effective than single agent treatments (p = 0.0057). The exhibited anti-tumor effect of these immunotherapeutic agents alone and in combination suggest that they may prove to be effective forms of immunotherapy for transitional cell carcinoma of the bladder.
AuthorsD R Riggs, W F Tarry, J I DeHaven, J Sosnowski, D L Lamm
JournalThe Journal of urology (J Urol) Vol. 147 Issue 1 Pg. 212-4 (Jan 1992) ISSN: 0022-5347 [Print] United States
PMID1729535 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • BCG Vaccine
  • Haptens
  • Interferon-alpha
  • Interleukin-2
  • Interferon-gamma
  • Hemocyanins
  • keyhole-limpet hemocyanin
Topics
  • Animals
  • BCG Vaccine (administration & dosage)
  • Carcinoma, Transitional Cell (pathology, therapy)
  • Cell Line
  • Haptens (administration & dosage)
  • Hemocyanins (administration & dosage)
  • Immunotherapy
  • Interferon-alpha (administration & dosage)
  • Interferon-gamma (administration & dosage)
  • Interleukin-2 (administration & dosage)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Neoplasm Transplantation
  • Urinary Bladder Neoplasms (pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: